Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Sep;131(17-18):442-445.
doi: 10.1007/s00508-019-01547-2. Epub 2019 Sep 6.

Acute liver failure in immunocompetent patients infected with hepatitis E

Affiliations
Case Reports

Acute liver failure in immunocompetent patients infected with hepatitis E

Christian Wenter et al. Wien Klin Wochenschr. 2019 Sep.

Abstract

In almost all immunocompetent patients an acute hepatitis E virus (HEV) infection is clinically silent with spontaneous viral clearance. So far, only a very small number of severe acute HEV infections have been described. This article reports the case of a 78-year-old immunocompetent, diabetic patient, who presented with a symptomatic acute HEV genotype (GT) 3 infection and that progressed to acute liver failure. After starting with an antiviral therapy with ribavirin, the HEV viral load rapidly decreased with a significant improvement of the laboratory parameters as well as a clinical amelioration of the patient. The treatment was continued for 3 months and led to a complete resolution of this acute fulminant hepatitis E. Although the risk is almost negligible this article clearly demonstrates that an acute liver failure due to HEV should also be considered in immunocompetent patients, especially in older male individuals with diabetes mellitus.

Keywords: Immunosuppression; Liver sausages; Ribavirin; Solid organ transplantation; Zoonotic infection.

PubMed Disclaimer

Conflict of interest statement

C. Wenter, W. Borena, G. Oberhuber, and I. Graziadei declare that they have no competing interests.

References

    1. Kamar N, Bendall R, Legrand-Abravanel F, et al. Hepatitis E. Lancet. 2012;379:2477–2488. doi: 10.1016/S0140-6736(11)61849-7. - DOI - PubMed
    1. Adlhoch C, Avellon A, Baylis SA, et al. Hepatitis E virus: assessment of the epidemiological situation in humans in Europe, 2014/15. J Clin Virol. 2016;82:9–16. doi: 10.1016/j.jcv.2016.06.010. - DOI - PubMed
    1. Hewitt PE, Ijaz S, Brailsford SR, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet. 2014;384:1766–1773. doi: 10.1016/S0140-6736(14)61034-5. - DOI - PubMed
    1. Bura M, Lagiedo M, Michalak M, Sikora J, Mozer-Lisewska I. Hepatitis E virus IgG seroprevalence in HIV patients and blood donors, west central Poland. Int J Infect Dis. 2017;61:20–22. doi: 10.1016/j.ijid.2017.05.014. - DOI - PubMed
    1. Kamar N, Dalton HR, Abravanel F, Izopet J. Hepatitis E virus infection. Clin Microbiol Rev. 2014;27:116–138. doi: 10.1128/CMR.00057-13. - DOI - PMC - PubMed

Publication types

LinkOut - more resources